NDC 60505-0096-01 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-0096
- Requested NDC
- 60505-0096-01
- Package NDCs from labels
- 60505-0096-0, 60505-0096-1, 60505-0096-8, 60505-0096-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - A-S Medication Solutions | A-S Medication Solutions | 2026-10-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - Apotex Corp. | Apotex Inc. | Apotex Corp. | Apotex Inc. | 2026-09-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - AvKARE | AvKARE | 2026-03-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - AvPAK | AvPAK | 2026-03-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2025-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - Legacy Pharmaceutical Packaging, LLC | Legacy Pharmaceutical Packaging, LLC | 2020-02-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-0096-0 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | 15 | |
| 60505-0096-1 | Doxazosin | 1000 in 1 BOTTLE | TABLET | 1000 | 15 | |
| 60505-0096-8 | Doxazosin | 5000 in 1 BOTTLE | TABLET | 5000 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-0096 | DOXAZOSIN TABLET [APOTEX CORP.] | 14 | Current NDC, Legacy NDC, 3 package rows | 20240822_4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0096-0 | EA - Each | 60505-0096 | 3376beac-ff37-4222-b9b3-6b5152d454ef | 1 | 2012-07-24 |
| 60505-0096-1 | EA - Each | 60505-0096 | a9f32422-499b-4773-83b8-1da702f75b76 | 1 | 2012-07-24 |
| 60505-0096-8 | EA - Each | 60505-0096 | bfa68409-7688-4ec4-a78b-de674507a91d | 1 | 2013-05-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | Zydus Pharmaceuticals USA Inc. | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 2023-09-16 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Chartwell RX, LLC | a7f589b0-eebb-48cb-912f-a4bd956e4dcb | 2023-06-09 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura XL | DOXAZOSIN MESYLATE | Viatris Specialty LLC | 355bcdce-0481-48ba-8ebd-2009106aaf77 | 2023-05-15 | Warnings, Adverse reactions | 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d | 2022-08-01 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | b364c7a8-72b5-4776-a500-400c37a72c9b | 2022-02-03 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Mylan Pharmaceuticals Inc. | 6b887aa5-5edf-48c5-a480-dea8c35afa9d | 2022-01-20 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura | DOXAZOSIN | ROERIG | eefc47bc-c10f-49bb-8ef7-5999f798ab39 | 2022-01-20 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | f1dc70f6-4329-46da-8990-7bd6eec9d37d | 2021-12-07 | Warnings, Adverse reactions | ANDA075580 197628 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Teva Pharmaceuticals USA, Inc. | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 2021-11-30 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 6b74b18f-b89a-4109-a29e-c4fa65a3c5ee | 2020-12-10 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| 814ec517-9a88-4263-9c8b-c51188503fdb | 71ab4b91-f9f3-4a0a-b880-7f884d9210f3 | 2020-02-13 | Warnings, Adverse reactions | 814ec517-9a88-4263-9c8b-c51188503fdb 71ab4b91-f9f3-4a0a-b880-7f884d9210f3 | ||
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 7e547752-a53a-4ad9-b70e-7cc2a1dd5d5d | 2018-03-06 | Warnings, Adverse reactions | ANDA075580 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.